These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18832472)

  • 1. Association of lipoprotein-associated phospholipase A2 mass and activity with coronary and aortic atherosclerosis: findings from the Dallas Heart Study.
    Brilakis ES; Khera A; Saeed B; Banerjee S; McGuire DK; Murphy SA; de Lemos JA
    Clin Chem; 2008 Dec; 54(12):1975-81. PubMed ID: 18832472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A₂ activity predicts progression of subclinical coronary atherosclerosis.
    Kinney GL; Snell-Bergeon JK; Maahs DM; Eckel RH; Ehrlich J; Rewers M; Hokanson JE
    Diabetes Technol Ther; 2011 Mar; 13(3):381-7. PubMed ID: 21291330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas Heart Study.
    Chen K; Lindsey JB; Khera A; De Lemos JA; Ayers CR; Goyal A; Vega GL; Murphy SA; Grundy SM; McGuire DK
    Diab Vasc Dis Res; 2008 Jun; 5(2):96-101. PubMed ID: 18537096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: the Dallas Heart Study.
    Chen LQ; Rohatgi A; Ayers CR; Das SR; Khera A; Berry JD; McGuire DK; de Lemos JA
    Atherosclerosis; 2011 Dec; 219(2):833-8. PubMed ID: 21917261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between C-reactive protein and atherosclerosis differs on the basis of body mass index: the Dallas Heart Study.
    Gupta NK; de Lemos JA; Ayers CR; Abdullah SM; McGuire DK; Khera A
    J Am Coll Cardiol; 2012 Sep; 60(13):1148-55. PubMed ID: 22939555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-associated phospholipase A2 and coronary calcification. The Rotterdam Coronary Calcification Study.
    Kardys I; Oei HH; Hofman A; Oudkerk M; Witteman JC
    Atherosclerosis; 2007 Apr; 191(2):377-83. PubMed ID: 16678183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and carotid atherosclerosis in Retired National Football League players.
    Pokharel Y; Nambi V; Martin SS; Hoogeveen RC; Nasir K; Khera A; Wong ND; Jones PH; Boone J; Roberts AJ; Ballantyne CM; Virani SS
    Atherosclerosis; 2014 Oct; 236(2):251-6. PubMed ID: 25105582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between peptidoglycan recognition protein-1 and coronary and peripheral atherosclerosis: Observations from the Dallas Heart Study.
    Rohatgi A; Ayers CR; Khera A; McGuire DK; Das SR; Matulevicius S; Timaran CH; Rosero EB; de Lemos JA
    Atherosclerosis; 2009 Apr; 203(2):569-75. PubMed ID: 18774573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study.
    Obisesan OH; Kou M; Wang FM; Boakye E; Honda Y; Uddin SMI; Dzaye O; Osei AD; Orimoloye OA; Howard-Claudio CM; Coresh J; Blumenthal RS; Hoogeveen RC; Budoff MJ; Matsushita K; Ballantyne CM; Blaha MJ
    J Am Heart Assoc; 2022 Jun; 11(11):e024870. PubMed ID: 35656990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study.
    See R; Abdullah SM; McGuire DK; Khera A; Patel MJ; Lindsey JB; Grundy SM; de Lemos JA
    J Am Coll Cardiol; 2007 Aug; 50(8):752-9. PubMed ID: 17707180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational studies of lipoprotein-associated phospholipase A₂ in inflammation and atherosclerosis.
    Ferguson JF; Hinkle CC; Mehta NN; Bagheri R; Derohannessian SL; Shah R; Mucksavage MI; Bradfield JP; Hakonarson H; Wang X; Master SR; Rader DJ; Li M; Reilly MP
    J Am Coll Cardiol; 2012 Feb; 59(8):764-72. PubMed ID: 22340269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study.
    Khera A; de Lemos JA; Peshock RM; Lo HS; Stanek HG; Murphy SA; Wians FH; Grundy SM; McGuire DK
    Circulation; 2006 Jan; 113(1):38-43. PubMed ID: 16380546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin reduces expression and activity of lipoprotein-associated phospholipase A(2) in the aorta of hypercholesterolaemic atherosclerotic rabbits.
    Qiao Z; Ren J; Chen H
    J Int Med Res; 2009; 37(4):1029-37. PubMed ID: 19761685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up.
    Rallidis LS; Tellis CC; Lekakis J; Rizos I; Varounis C; Charalampopoulos A; Zolindaki M; Dagres N; Anastasiou-Nana M; Tselepis AD
    J Am Coll Cardiol; 2012 Nov; 60(20):2053-60. PubMed ID: 23083783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults: the CARDIA study.
    Iribarren C; Gross MD; Darbinian JA; Jacobs DR; Sidney S; Loria CM
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):216-21. PubMed ID: 15499045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between plasma caspase-3, atherosclerosis, and vascular function in the Dallas Heart Study.
    Matulevicius S; Rohatgi A; Khera A; Das SR; Owens A; Ayers CR; Timaran CH; Rosero EB; Drazner MH; Peshock RM; de Lemos JA
    Apoptosis; 2008 Oct; 13(10):1281-9. PubMed ID: 18763039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between serum lipoprotein(a) levels and the severity of coronary and aortic atherosclerosis.
    Momiyama Y; Ohmori R; Fayad ZA; Tanaka N; Kato R; Taniguchi H; Nagata M; Ohsuzu F
    Atherosclerosis; 2012 May; 222(1):241-4. PubMed ID: 22387060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT).
    Saremi A; Anderson RJ; Luo P; Moritz TE; Schwenke DC; Allison M; Reaven PD;
    Atherosclerosis; 2009 Apr; 203(2):610-4. PubMed ID: 18804762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-specific associations of lipoprotein(a) with presence and quantity of coronary artery calcification in an asymptomatic population.
    Cassidy AE; Bielak LF; Kullo IJ; Klee GG; Turner ST; Sheedy PF; Peyser PA
    Med Sci Monit; 2004 Sep; 10(9):CR493-503. PubMed ID: 15328481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.